论文信息 - Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma - 字舞流文

Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma

M. Pajares | A. Hernández-Laín | P. Sánchez-Gómez | D. Cantero | J. Sepúlveda | C. Zahonero | Á. Pérez-Núñez | C. Ramírez-Castillejo | M. Bolós | P. Aguilera | Marta Pajares | Diana Cantero